Investors
Although legal marijuana is certainly proliferating, investors know that this does not necessarily translate into certain profits. Data is needed to find new areas of investment where growing demand meets a favorable regulatory environment. We strive to make investment decisions more robust by providing the most granular data possible with our marijuana-demand statistics at the county- and even zip-code-level. With holistic data on both consumers and producers, Higher Data can inform a broad range of investment strategies in publicly traded marijuana companies.
Beyond marijuana investments, our medical marijuana patient-count data has been shown to be a significant predictor of sales of products impacted by medical marijuana, including various pharmaceutical drugs and alcoholic beverages. How marijuana affects demand for potential substitutes and complements is rather unknown, but our data and analytics can help traditional investors understand how recreational and medical marijuana legalization will affect adjacent industries.
Higher Data has ranked the top cannabis brands entering 2020. Using our real-time dispensary menu data, we ranked brands based on the number of products each has stocked in medical and recreational dispensaries across North America.